

Cover Story
Capitol HillFree
By Matthew Bin Han Ong
After taking eight months to respond to a House committee’s questions about policies on handling of sexual misconduct cases, a letter from NIH has provided answers that critics describe as vague and inadequate.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president
- Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology